Molecular Profiling of Aggressive Lymphomas

In the last years, several studies of molecular profiling of aggressive lymphomas were performed. In particular, it was shown that DLBCL can be distinguished in two different entities according to GEP. Specifically, ABC and GCB subtypes were characterized by having different pathogenetic and clinica...

Full description

Bibliographic Details
Main Authors: Maura Rossi, Maria Antonella Laginestra, Anna Gazzola, Maria Rosaria Sapienza, Stefano A. Pileri, Pier Paolo Piccaluga
Format: Article
Language:English
Published: Hindawi Limited 2012-01-01
Series:Advances in Hematology
Online Access:http://dx.doi.org/10.1155/2012/464680
id doaj-ddbeef592c18464483a06d7c9f852103
record_format Article
spelling doaj-ddbeef592c18464483a06d7c9f8521032021-07-02T02:06:29ZengHindawi LimitedAdvances in Hematology1687-91041687-91122012-01-01201210.1155/2012/464680464680Molecular Profiling of Aggressive LymphomasMaura Rossi0Maria Antonella Laginestra1Anna Gazzola2Maria Rosaria Sapienza3Stefano A. Pileri4Pier Paolo Piccaluga5Molecular Pathology Laboratory, Haematopathology Unit, Department of Haematology and Oncology “L. and A. Seràgnoli”, S. Orsola-Malpighi Hospital, University of Bologna, Via Massarenti 9, 40138 Bologna, ItalyMolecular Pathology Laboratory, Haematopathology Unit, Department of Haematology and Oncology “L. and A. Seràgnoli”, S. Orsola-Malpighi Hospital, University of Bologna, Via Massarenti 9, 40138 Bologna, ItalyMolecular Pathology Laboratory, Haematopathology Unit, Department of Haematology and Oncology “L. and A. Seràgnoli”, S. Orsola-Malpighi Hospital, University of Bologna, Via Massarenti 9, 40138 Bologna, ItalyMolecular Pathology Laboratory, Haematopathology Unit, Department of Haematology and Oncology “L. and A. Seràgnoli”, S. Orsola-Malpighi Hospital, University of Bologna, Via Massarenti 9, 40138 Bologna, ItalyMolecular Pathology Laboratory, Haematopathology Unit, Department of Haematology and Oncology “L. and A. Seràgnoli”, S. Orsola-Malpighi Hospital, University of Bologna, Via Massarenti 9, 40138 Bologna, ItalyMolecular Pathology Laboratory, Haematopathology Unit, Department of Haematology and Oncology “L. and A. Seràgnoli”, S. Orsola-Malpighi Hospital, University of Bologna, Via Massarenti 9, 40138 Bologna, ItalyIn the last years, several studies of molecular profiling of aggressive lymphomas were performed. In particular, it was shown that DLBCL can be distinguished in two different entities according to GEP. Specifically, ABC and GCB subtypes were characterized by having different pathogenetic and clinical features. In addition, it was demonstrated that DLBCLs are distinct from BL. Indeed, the latter is a unique molecular entity. However, relevant pathological differences emerged among the clinical subtypes. More recently, microRNA profiling provided further information concerning BL-DLBCL distinction as well as for their subclassification. In this paper, the authors based on their own experience and the most updated literature review, the main concept on molecular profiling of aggressive lymphomas.http://dx.doi.org/10.1155/2012/464680
collection DOAJ
language English
format Article
sources DOAJ
author Maura Rossi
Maria Antonella Laginestra
Anna Gazzola
Maria Rosaria Sapienza
Stefano A. Pileri
Pier Paolo Piccaluga
spellingShingle Maura Rossi
Maria Antonella Laginestra
Anna Gazzola
Maria Rosaria Sapienza
Stefano A. Pileri
Pier Paolo Piccaluga
Molecular Profiling of Aggressive Lymphomas
Advances in Hematology
author_facet Maura Rossi
Maria Antonella Laginestra
Anna Gazzola
Maria Rosaria Sapienza
Stefano A. Pileri
Pier Paolo Piccaluga
author_sort Maura Rossi
title Molecular Profiling of Aggressive Lymphomas
title_short Molecular Profiling of Aggressive Lymphomas
title_full Molecular Profiling of Aggressive Lymphomas
title_fullStr Molecular Profiling of Aggressive Lymphomas
title_full_unstemmed Molecular Profiling of Aggressive Lymphomas
title_sort molecular profiling of aggressive lymphomas
publisher Hindawi Limited
series Advances in Hematology
issn 1687-9104
1687-9112
publishDate 2012-01-01
description In the last years, several studies of molecular profiling of aggressive lymphomas were performed. In particular, it was shown that DLBCL can be distinguished in two different entities according to GEP. Specifically, ABC and GCB subtypes were characterized by having different pathogenetic and clinical features. In addition, it was demonstrated that DLBCLs are distinct from BL. Indeed, the latter is a unique molecular entity. However, relevant pathological differences emerged among the clinical subtypes. More recently, microRNA profiling provided further information concerning BL-DLBCL distinction as well as for their subclassification. In this paper, the authors based on their own experience and the most updated literature review, the main concept on molecular profiling of aggressive lymphomas.
url http://dx.doi.org/10.1155/2012/464680
work_keys_str_mv AT maurarossi molecularprofilingofaggressivelymphomas
AT mariaantonellalaginestra molecularprofilingofaggressivelymphomas
AT annagazzola molecularprofilingofaggressivelymphomas
AT mariarosariasapienza molecularprofilingofaggressivelymphomas
AT stefanoapileri molecularprofilingofaggressivelymphomas
AT pierpaolopiccaluga molecularprofilingofaggressivelymphomas
_version_ 1721343885900251136